Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Neutral

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Monopar Therapeutics Inc. Common Stock (MNPR)

Pharmaceutical Preparations

https://www.monopartx.com

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of advanced soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for advanced cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

1000 SKOKIE BLVD SUITE 350
WILMETTE, IL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

12/19/2019

Market Cap

8,237,666

Shares Outstanding

14,870,000

Weighted SO

14,866,400

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

ANEB --.--%

ACRV --.--%

PMVP --.--%

MOLN --.--%

MLYS --.--%

CADL --.--%

ACXP --.--%

ENOB --.--%

SCPH --.--%

Beta

1.1840

Last Div

0.0000

Range

1.3695-8.65

Chg

-0.0300

Avg Vol

26642

Mkt Cap

8237666

Exch

NASDAQ

Country

US

Phone

847 388 0349

DCF Diff

-0.2881

DCF

2.6281

Div Yield

0.0000

P/S

0.0000

EV Multiple

-0.2827

P/FV

1.3459

Div Yield %

0.0000

P/E

-1.1506

PEG

0.0043

Payout

0.0000

Current Ratio

6.5902

Quick Ratio

6.5902

Cash Ratio

5.6174

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

0.0000

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

-15.4994

ROA

-0.9923

ROE

-1.1060

ROCE

-1.2298

NI/EBT

1.0000

EBT/EBIT

0.9511

EBIT/Rev

0.0000

Debt Ratio

0.0000

D/E

0.0000

LT Debt/Cap

0.0000

Total Debt/Cap

0.0000

Int Coverage

-82.7751

CF/Debt

0.0000

Equity Multi

1.1789

Rec Turnover

0.0000

Pay Turnover

0.0000

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-1.9464

FCF/Share

-1.9464

Cash/Share

2.0322

OCF/Sales

0.0000

FCF/OCF

1.0000

CF Coverage

0.0000

ST Coverage

0.0000

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

1.3459

P/B

1.3459

P/S

0.0000

P/E

-1.1506

P/FCF

-1.2082

P/OCF

-1.2022

P/CF

-1.2022

PEG

0.0043

P/S

0.0000

EV Multiple

-0.2827

P/FV

1.3459

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Oct 29, 01:15 Monopar Therapeutics Inc. Announces Pricing of $19.2 Million Public Offering of Common Stock

Revenue Product Segmentation